Elliot builds a sizeable stake in life science tool supplier Bio-Rad (BIO), according to WSJ

Elliot's acquisition of a significant stake in Bio-Rad signals confidence in the company’s growth potential within the life sciences sector.

Newsquawk StaffPublished On the live feed at 4 more headlines followed before this page went public
Newsquawk headlinesUTC

Korea Exchange activated a sidecar on the KOSPI after KOSPI 200 futures fell 5%, with programme trading halted for 5 minutes

PBoC is expected to set USD/CNY mid-point at 6.8086 (prev. 6.8415)

Elliot builds a sizeable stake in life science tool supplier Bio-Rad (BIO), according to WSJ

[MARKET ANALYSIS] Asia-Pac stocks begin mostly lower amid higher yields and rising oil prices after US President Trump warned the clock is ticking for Iran

PRE-MARKET AUSTRALIAN, JAPANESE & SOUTH KOREAN STOCK NEWS: Earnings from Japan Post, Japan Post Bank, Mitsubishi UFJ & Mizuho Financial Group, Samsung Electronics strike draws near

Open the platform and use it. The whole workspace is free to try, with no signup and no card. When you want the headlines arriving live instead of on a delay, Newsquawk Pro is £24.99 for 7 days.

Free. No signup, no card.
Context

This move may trigger speculation on further consolidation in the industry, potentially positioning Bio-Rad as a strategic target for M&A activity. Keep an eye on potential market reactions and how this might influence peers within the life sciences and biotechnology space.

Related headlines

The whole workspace, free to try.

Try it free